IRADIMED CEO trust sells 7,500 shares under plan
IRADIMED CORP director and CEO Roger E. Susi reported indirect open-market sales of 7,500 shares of common stock on April 13–14, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
IRADIMED CORP director and CEO Roger E. Susi reported indirect open-market sales of 7,500 shares of common stock on April 13–14, 2026. The transactions were executed by the Phillip Susi 2008 Dynasty Trust at weighted average prices around $92–$94 per share under a Rule 10b5-1 trading plan adopted on November 5, 2025. Following these sales, the Phillip Susi 2008 Dynasty Trust held 2,210,000 shares indirectly, while separate indirect holdings reported include 162,950 shares held by the Roger E. Susi Revocable Trust and 2,062,500 shares held by the Matthew Susi 2008 Dynasty Trust as of April 13, 2026.
Insider Trade Summary 10b5-1
Net Seller: 7,500 shares
Net Sell
7 txns
Insider
Susi Roger E.
Role
CEO, President, Chairman
Sold
7,500 shs ($697K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,107 | $93.71 | $197K |
| Sale | Common Stock | 393 | $94.55 | $37K |
| Sale | Common Stock | 1,847 | $91.84 | $170K |
| Sale | Common Stock | 2,564 | $92.79 | $238K |
| Sale | Common Stock | 589 | $93.45 | $55K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 2,210,000 shares (Indirect, By Phillip Susi 2008 Dynasty Trust);
Common Stock — 162,950 shares (Indirect, By Roger E. Susi Revocable Trust);
Common Stock — 2,062,500 shares (Indirect, By Matthew Susi 2008 Dynasty Trust)
Footnotes (7)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025.
- F2. This transaction was executed in multiple trades at prices ranging from $91.28 to $92.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. This transaction was executed in multiple trades at prices ranging from $92.35 to $93.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $93.29 to $94.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $93.17 to $94.13. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $94.24 to $94.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.
Key Figures
Shares sold: 7,500 shares
Sale price (low): $91.84 per share
Sale price (high): $94.55 per share
+4 more
7 metrics
Shares sold
7,500 shares
Net open-market sales on April 13–14, 2026
Sale price (low)
$91.84 per share
Weighted average sale price on April 13, 2026
Sale price (high)
$94.55 per share
Weighted average sale price on April 14, 2026
Phillip Susi 2008 Dynasty Trust holdings
2,210,000 shares
Indirect common stock after April 14, 2026 sales
Roger E. Susi Revocable Trust holdings
162,950 shares
Indirect common stock as of April 13, 2026
Matthew Susi 2008 Dynasty Trust holdings
2,062,500 shares
Indirect common stock as of April 13, 2026
Rule 10b5-1 plan adoption date
November 5, 2025
Plan governing the April 2026 share sales
Key Terms
Rule 10b5-1 trading plan, weighted average sale price, Section 16, beneficial ownership, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sale price financial
"The price reported above reflects the weighted average sale price"
Section 16 regulatory
"shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
beneficial ownership financial
"The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
open-market sale financial
"transaction_action: open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Were the IRADIMED (IRMD) insider sales made under a Rule 10b5-1 plan?
Yes. A footnote states the sales were effected under a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. Such plans pre-schedule trades, making the timing more routine and less discretionary.
What other IRADIMED (IRMD) indirect holdings are reported for Roger E. Susi in this Form 4?
Beyond the dynasty trust, the filing lists 162,950 shares held by the Roger E. Susi Revocable Trust and 2,062,500 shares held by the Matthew Susi 2008 Dynasty Trust, both reported as indirect holdings as of April 13, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates